Nabil Shabshab - Inogen President, Chief Executive Officer, Director

6IO Stock  EUR 11.90  0.50  4.39%   

CEO

Nabil Shabshab is President, Chief Executive Officer, Director of Inogen Inc since 2021.
Age 58
Tenure 4 years
Phone805 562 0500
Webhttps://www.inogen.com

Inogen Management Efficiency

The company has return on total asset (ROA) of (0.0677) % which means that it has lost $0.0677 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.2509) %, meaning that it generated substantial loss on money invested by shareholders. Inogen's management efficiency ratios could be used to measure how well Inogen manages its routine affairs as well as how well it operates its assets and liabilities.
Inogen Inc has accumulated 28.47 M in total debt with debt to equity ratio (D/E) of 0.08, which may suggest the company is not taking enough advantage from borrowing. Inogen Inc has a current ratio of 5.19, suggesting that it is liquid and has the ability to pay its financial obligations in time and when they become due. Debt can assist Inogen until it has trouble settling it off, either with new capital or with free cash flow. So, Inogen's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Inogen Inc sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Inogen to invest in growth at high rates of return. When we think about Inogen's use of debt, we should always consider it together with cash and equity.

Similar Executives

Found 1 records

CEO Age

Michael OSullivanBURLINGTON STORES
55
Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California. INOGEN INC operates under Medical Devices classification in Germany and is traded on Frankfurt Stock Exchange. It employs 938 people. Inogen Inc (6IO) is traded on Frankfurt Exchange in Germany and employs 1,026 people.

Management Performance

Inogen Inc Leadership Team

Elected by the shareholders, the Inogen's board of directors comprises two types of representatives: Inogen inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Inogen. The board's role is to monitor Inogen's management team and ensure that shareholders' interests are well served. Inogen's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Inogen's outside directors are responsible for providing unbiased perspectives on the board's policies.
Scott Beardsley, Independent Director
Nabil Shabshab, President, Chief Executive Officer, Director
Heather Rider, Independent Director
Bart Sanford, Executive Vice President Operations
Agnes Lee, VP Planning
Jason Somer, Gen VP
Jennifer Boyer, Ex Officer
Loren McFarland, Independent Director
Arron Retterer, Executive Vice President of Sales
Benjamin AndersonRay, Independent Director
Scott Wilkinson, President, Chief Executive Officer, Director
Brenton Taylor, Executive Vice President - Engineering
R Greer, Independent Director
MBA MD, Ex CTO
George Parr, Ex Officer
Matthew Pigeon, Investor Officer
Kristin Caltrider, CFO VP
Byron Myers, Executive Vice President of Sales and Marketing
Kristen Miranda, Director
Raymond Huggenberger, Independent Director
Heath Lukatch, Independent Chairman of the Board
Alison Bauerlein, Executive Vice President - Finance and Chief Financial Officer, Corporate Secretary and Corporate Treasurer

Inogen Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Inogen a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Currently Active Assets on Macroaxis

Additional Information and Resources on Investing in Inogen Stock

When determining whether Inogen Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Inogen's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Inogen Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Inogen Inc Stock:
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Inogen Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Please note, there is a significant difference between Inogen's value and its price as these two are different measures arrived at by different means. Investors typically determine if Inogen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Inogen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.